Discover Quanterix Simoa Technology
Digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. Quanterix enables development of methods providing much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come.
Quanterix Portfolio consists of
HD-X Analyzer™
Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability.
1000x
Up to 1000x greater sensitivity
6 in 1
Up to 6 biomarkers in a single assay
80+
Compatible with 80+ assays
SP-X Imaging and Analysis System™
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex biomarker detection – even at healthy baseline levels.
1000x
Up to 1000x greater sensitivity
10 in 1
Up to 10 biomarkers in a single assay
100+
Compatible with 100+ assays
SR-X™ Biomarker Detection System
Offers researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system.
1000x
Up to 1000x greater sensitivity
6 in 1
Up to 6 biomarkers in a single assay
30+
Compatible with 30+ assays
Ready-to-use Simoa® kits contain all the reagents necessary to run your assay on the HD-1, HD-X , SR-X or SP-X platforms. Our broad portfolio of available kits spans multiple therapeutic areas including cardiology, infectious disease, inflammation, neurology, and oncology.
Learn more of the assays here